[Skip to Navigation]
Sign In
Figure 1.  Cumulative Annual Deaths Among People Experiencing Homelessness in San Francisco From January 1, 2018, to March 16, 2021
Cumulative Annual Deaths Among People Experiencing Homelessness in San Francisco From January 1, 2018, to March 16, 2021
Figure 2.  Annual Deaths and All-Cause Mortality Rates per 100 000 Among People Experiencing Homelessness in San Francisco From January 1, 2016, to March 16, 2021
Annual Deaths and All-Cause Mortality Rates per 100 000 Among People Experiencing Homelessness in San Francisco From January 1, 2016, to March 16, 2021

aFrom March 17, 2020, to March 16, 2021.

Table 1.  Characteristics of Deaths Among People Experiencing Homelessness in San Francisco, by Year
Characteristics of Deaths Among People Experiencing Homelessness in San Francisco, by Year
Table 2.  Causes of Death Among People Experiencing Homelessness in San Francisco, by Year
Causes of Death Among People Experiencing Homelessness in San Francisco, by Year
1.
Cawley  CL, Kanzaria  HK, Kushel  M, Raven  MC, Zevin  B.  Mortality among people experiencing homelessness in San Francisco 2016-2018.   J Gen Intern Med. 2021. doi:10.1007/s11606-021-06769-7 PubMedGoogle Scholar
2.
Imbert  E, Kinley  PM, Scarborough  A,  et al.  Coronavirus disease 2019 outbreak in a San Francisco homeless shelter.   Clin Infect Dis. 2021;73(2):324-327. doi:10.1093/cid/ciaa1071 PubMedGoogle ScholarCrossref
3.
City and County of San Francisco. COVID-19 Alternative Shelter Program. SF.gov. COVID-19 data and reports. Accessed August 27, 2021. https://sf.gov/data/covid-19-alternative-shelter-program
4.
Office of the Chief Medical Examiner. How is a medical examiner different from a coroner? City and County of San Francisco. Accessed February 1, 2022. https://sf.gov/information/how-medical-examiner-different-coroner
5.
Kanzaria  HK, Niedzwiecki  M, Cawley  CL,  et al.  Frequent emergency department users: focusing solely on medical utilization misses the whole person.   Health Aff (Millwood). 2019;38(11):1866-1875. doi:10.1377/hlthaff.2019.00082 PubMedGoogle ScholarCrossref
6.
Henry  M, De Sousa  T, Roddey  C, Gayen  S, Bednar  TJ. The 2020 Annual Homeless Assessment Report (AHAR) to Congress. US Department of Housing and Urban Development, Office of Community Planning and Development. Accessed February 1, 2022. https://www.huduser.gov/portal/sites/default/files/pdf/2020-AHAR-Part-1.pdf
7.
San Francisco Department of Homelessness and Supportive Housing.  San Francisco Homeless Count and Survey, Comprehensive Report. Applied Survey Research; 2020.
8.
United States Census Bureau. QuickFacts. San Francisco County California. Accessed February 1, 2022. https://www.census.gov/quickfacts/sanfranciscocountycalifornia
9.
Riley  ED, Raven  MC, Dilworth  SE, Braun  C, Imbert  E, Doran  KM.  Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic.   Int J Drug Policy. 2021;97:103405. doi:10.1016/j.drugpo.2021.103405 PubMedGoogle Scholar
10.
Woolf  SH, Chapman  DA, Sabo  RT, Zimmerman  EB.  Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021.   JAMA. 2021;325(17):1786-1789. doi:10.1001/jama.2021.5199 PubMedGoogle ScholarCrossref
11.
Mattson  CL, Tanz  LJ, Quinn  K, Kariisa  M, Patel  P, Davis  NL.  Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013-2019.   MMWR Morb Mortal Wkly Rep. 2021;70(6):202-207. doi:10.15585/mmwr.mm7006a4 PubMedGoogle ScholarCrossref
12.
Fine  DR, Dickins  KA, Adams  LD,  et al.  Drug overdose mortality among people experiencing homelessness, 2003 to 2018.   JAMA Netw Open. 2022;5(1):e2142676. doi:10.1001/jamanetworkopen.2021.42676 PubMedGoogle Scholar
13.
Doran  KM, Fockele  CE, Maguire  M.  Overdose and homelessness—why we need to talk about housing.   JAMA Netw Open. 2022;5(1):e2142685. doi:10.1001/jamanetworkopen.2021.42685 PubMedGoogle Scholar
14.
Appa  A, Rodda  LN, Cawley  C,  et al.  Drug overdose deaths before and after shelter-in-place orders During the COVID-19 pandemic in San Francisco.   JAMA Netw Open. 2021;4(5):e2110452. doi:10.1001/jamanetworkopen.2021.10452 PubMedGoogle Scholar
16.
New York City Department of Health and Mental Hygiene, New York City Department of Homeless Services. Fifteenth Annual Report on Deaths among Persons Experiencing Homelessness (July 1, 2019 – June 30, 2020). Accessed February 1, 2022. https://a860-gpp.nyc.gov/concern/nyc_government_publications/pz50gz035?locale=en
17.
Fowle  M, Gray  F. COVID-19 homeless deaths. Homeless Deaths Count. Accessed January 15, 2022. https://homelessdeathscount.org/data/covid-19/
18.
Cowan  J. San Francisco’s homeless population is much bigger than thought, city data suggests. New York Times. November 19, 2019. Accessed January 15, 2022. https://www.nytimes.com/2019/11/19/us/san-francisco-homeless-count.html
Original Investigation
Public Health
March 10, 2022

Mortality Among People Experiencing Homelessness in San Francisco During the COVID-19 Pandemic

Author Affiliations
  • 1Department of Emergency Medicine, University of California, San Francisco
  • 2Benioff Homelessness and Housing Initiative, Center for Vulnerable Populations, University of California, San Francisco
  • 3Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco
  • 4Street Medicine and Shelter Health, San Francisco Department of Public Health, San Francisco, California
  • 5Departments of Emergency Medicine and Population Health, New York University Grossman School of Medicine, New York
JAMA Netw Open. 2022;5(3):e221870. doi:10.1001/jamanetworkopen.2022.1870
Key Points

Question  How did the number and characteristics of deaths among people experiencing homelessness in San Francisco during the COVID-19 pandemic compare with those in prior years?

Findings  In this cross-sectional study, more than twice as many people died while homeless in the year starting March 17, 2020, compared with any prior year.

Meaning  The number of deaths in San Francisco among people experiencing homelessness increased markedly during the COVID-19 pandemic, with most of the increase associated with overdose deaths rather than COVID-19 itself.

Abstract

Importance  There has been recent media attention on the risk of excess mortality among homeless individuals during the COVID-19 pandemic, yet data on these deaths are limited.

Objectives  To quantify and describe deaths among people experiencing homelessness in San Francisco during the COVID-19 pandemic and to compare the characteristics of these deaths with those in prior years.

Design, Setting, and Participants  A cross-sectional study tracking mortality among people experiencing homelessness from 2016 to 2021 in San Francisco, California. All deceased individuals who were homeless in San Francisco at the time of death and whose deaths were processed by the San Francisco Office of the Chief Medical Examiner were included. Data analysis was performed from August to October 2021.

Exposure  Homelessness, based on homeless living status in an administrative database.

Main Outcomes and Measures  Descriptive statistics were used to understand annual trends in demographic characteristics, cause and manner of death (based on autopsy), substances present in toxicology reports, geographic distribution of deaths, and use of health and social services prior to death. Total estimated numbers of people experiencing homelessness in San Francisco were assessed through semiannual point-in-time counts. The 2021 point-in-time count was postponed owing to the COVID-19 pandemic.

Results  In San Francisco, there were 331 deaths among people experiencing homelessness in the first year of the COVID-19 pandemic (from March 17, 2020, to March 16, 2021). This number was more than double any number in previous years (eg, 128 deaths in 2016, 128 deaths in 2017, 135 deaths in 2018, and 147 deaths in 2019). Most individuals who died were male (268 of 331 [81%]). Acute drug toxicity was the most common cause of death in each year, followed by traumatic injury. COVID-19 was not listed as the primary cause of any deaths. The proportion of deaths involving fentanyl increased each year (present in 52% of toxicology reports in 2019 and 68% during the pandemic). Fewer decedents had contacts with health services in the year prior to their death during the pandemic than in prior years (13% used substance use disorder services compared with 20% in 2019).

Conclusions and Relevance  In this cross-sectional study, the number of deaths among people experiencing homelessness in San Francisco increased markedly during the first year of the COVID-19 pandemic. These findings may guide future interventions to reduce mortality among individuals experiencing homelessness.

Introduction

San Francisco has been tracking deaths among people experiencing homelessness using standardized methods since 2016.1 Early in the COVID-19 pandemic, there was concern about the potential for high rates of COVID-19 transmission and mortality among people experiencing homelessness.2 To mitigate this risk, San Francisco placed several thousand people experiencing homelessness at high risk of severe complications from COVID-19 in shelter-in-place hotel rooms, reduced the number of people in shelters, and offered mitigation strategies in sheltered and unsheltered settings.3 In this study, we describe deaths among people experiencing homelessness in the first year of the pandemic (from March 17, 2020, to March 16, 2021) and compare the characteristics of these deaths with those of the deaths in 4 preceding calendar years. We sought to understand the factors associated with mortality among people experiencing homelessness and to inform mortality prevention strategies.

Methods

In this cross-sectional study, to assess the number of deaths among people experiencing homelessness in San Francisco, California, we reviewed records from the San Francisco Office of the Chief Medical Examiner (OCME).4 The OCME provides forensic death investigation services for the City and County of San Francisco and generates reports providing manner, cause, location, and date of death. Cases also include autopsy and toxicology reports, except in situations involving a lengthy hospital stay prior to death because, when measured weeks into a hospitalization, postmortem toxicology would not accurately reflect substances that may have been present at the time of admission. We linked these data to the San Francisco Department of Public Health (SFDPH) Coordinated Care Management System (CCMS) to obtain data on demographic characteristics, homelessness history, and the use of medical services, behavioral health services, county jail health services, shelter-in-place hotels, and shelters prior to death for each decedent. The CCMS defines homelessness based on either data on homeless service use or data on self-reported homeless status collected during health or social service encounters. The SFDPH creates a CCMS record for any individual noted as homeless in any San Francisco County health or housing data system, any individual using county behavioral health, homelessness, or jail health services, or any individual using county urgent or emergent medical, mental health, or substance use services. Descriptions of these data sources can be found elsewhere.1,5 We categorized decedents as homeless if they met at least 1 criterion for the US Department of Housing and Urban Development definition of homelessness.6 We obtained institutional review board approval from the University of California, San Francisco and adhered to the Protected Health Information and Code of Federal Regulations 42 part 2 protocols governing the use of substance use disorder treatment data. Informed consent was not provided because the study did not involve contact with individuals (all individuals were deceased). Our report follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for observational cross-sectional studies.

Statistical Analysis

We calculated homeless death estimates for a 12-month period starting March 17, 2020 (the date of San Francisco’s shelter-in-place order), and compared these estimates with the annual estimates for the calendar years 2016 to 2019. We expressed estimates as rates per 100 000 based on semiannual point-in-time counts of homelessness7 to account for relative changes in the homeless population over time. For example, there were 6858 individuals in 2017 and 8035 individuals in 2019. The 2021 point-in-time count was postponed owing to the COVID-19 pandemic. We used descriptive statistics (SAS, version 9.4 [SAS Institute]) to understand trends in demographic characteristics, living situations, causes and locations of death, toxicology findings, and use of health and social services in the year prior to death.

Results

In the first year of the pandemic (from March 17, 2020, to March 16, 2021), there were 331 deaths among people experiencing homelessness, more than double the annual total of any previous year (128 in 2016, 128 in 2017, 135 in 2018, and 147 in 2019). There was an inflection point of increased mortality shortly after shelter-in-place began (Figure 1). The all-cause mortality rate also doubled, from 1829 per 100 000 in 2019 to 4119 per 100 000 in the first year of the pandemic (Figure 2). The demographic characteristics of decedents remained similar across study years (Table 1) and were similar to the general homeless population in San Francisco; most were men aged 40 to 60 years, had been experiencing homelessness for at least 5 years, and disproportionately identified as African American or Black (22%-31%) relative to the general population of San Francisco (5.6%).8

The proportion of deaths due to overdose increased since we began gathering data (34% [39 of 116] in 2016, 34% [36 of 107] in 2017, 56% [66 of 118] in 2018, and 72% [98 of 137] in 2019); that trend continued during the COVID-19 pandemic, reaching 82% (178 of 216). Traumatic injuries (including homicides and suicides) were the second leading cause of death each year (Table 2), followed by chronic medical conditions (eg, cardiovascular disease and cancer). All decedents were tested for COVID-19. Four individuals tested positive either post mortem or during the hospital admission preceding their death, but COVID-19 was not listed as the primary cause of death in any of these cases. Deaths involving fentanyl increased throughout the study period. In 2016 and 2017, there were few fentanyl-involved cases (6% [6 of 97] and 7% [7 of 96] of toxicology reports, respectively), increasing to 30% (32 of 106) of toxicology reports in 2018, 52% (67 of 128) in 2019, and 68% (144 of 213) during the pandemic year. In every year, methamphetamines were the most common substances present in toxicology reports (48% [47 of 97] in 2016, 46% [44 of 96] in 2017, 66% [70 of 106] in 2018, 79% [101 of 128] in 2019, and 77% [164 of 213] during the pandemic).

Of the 869 deaths, 442 (51%) occurred outdoors (eg, sidewalk and park) in all study years. There were 54 deaths in which the death or precipitating incident occurred in shelter-in-place hotel rooms (eg, overdose in shelter-in-place room followed by death while hospitalized), plus an additional 16 shelter-in-place guests who died elsewhere (eg, friend’s residence). The all-cause mortality rate for shelter-in-place guests was 1811 per 100 000 (based on the alternate shelter program having served 3864 guests in shelter-in-place hotels or trailers3) compared with an estimated 5038 per 100 000 for non–shelter-in-place guests (based on the most recent point-in-time count of unsheltered individuals in San Francisco).

More than 90% of decedents in each year were successfully matched to CCMS, indicating that they were previously known to San Francisco public health and social services. Among those who died in the pandemic year, two-thirds (64% [212 of 331]) used medical services (acute care and/or outpatient [eg, emergency departments and SFDPH primary care clinics]) in the 12 months prior to death compared with 76% (112 of 147) in 2019. Of 331 decedents, 79 (24%) had contact with mental health services (eg, psychiatric emergency services and behavioral health case management), and 43 (13%) had contact with substance use disorder services (eg, sobering center and residential detoxification), compared with 30% (44 of 147) and 20% (30 of 147), respectively, in 2019 in the 12 months prior to death. Of 331 decedents, 86 (26%) had been in county jail custody in the year prior to death (compared with 35% [52 of 147] in 2019).

Discussion

Deaths among people experiencing homelessness in San Francisco more than doubled to 331 deaths during the first year of the COVID-19 pandemic, driven by a large increase in overdose deaths. No deaths in our data set were due to COVID-19 itself, which may speak to the success of San Francisco’s efforts to mitigate the spread of the virus in vulnerable populations, including by moving individuals at high risk into noncongregate settings. However, the pandemic had far-reaching effects on outreach, health, and social services (eg, temporary closures or reduced hours for drop-in behavioral health facilities; decreased capacity in residential facilities to allow social distancing; and staff redeployments to COVID-19–related roles) that may have contributed to increased mortality from non–COVID-19 causes. In a study of women who were homeless or unstably housed in San Francisco, some study participants reported increased difficulties getting care for chronic medical conditions, mental health, and substance use during the pandemic.9 The general population of the US has also experienced an increase in excess deaths not attributed to COVID-19 during the pandemic.10

This disruption to services coincided with increasing unintended overdose deaths in San Francisco, driven by the growing presence of fentanyl. There was a continued increase in the proportion of deaths among people experiencing homelessness associated with overdoses compared with 2019 (72% in 2019 and 82% in the study year), which followed a years-long upward trend, and the absolute number of overdose deaths increased markedly. From 2018 to 2019, the Western US experienced a large increase in death rates involving synthetic opioids, such as fentanyl.11 In Boston, Massachusetts, the synthetic opioid mortality rate among people experiencing homelessness increased by more than 1400% between 2013 and 2018. This homeless cohort’s standardized mortality rate from overdose for the years 2003 to 2018 was also 12 times higher than that of the adult population of Massachusetts.12,13 A study of total overdose deaths in San Francisco found a 50% increase in weekly median overdose deaths since the onset of the pandemic.14

COVID-19 mitigation policies may have affected how, when, and where people used drugs and the chances a passerby could intervene in case of an overdose. COVID-19–related effects on the health system may have led to decreased access to treatment. We found that a low proportion of decedents had recent contact with behavioral health services, including office-based substance use disorder treatment programs. Our data on substance use services do not capture information on all of San Francisco’s overdose prevention programs (eg, naloxone distribution), but our findings point to a need for more programs to address substance use disorder and overdose risk among people experiencing homelessness. San Francisco’s alternative shelter program (shelter-in-place hotels) did not appear to be associated with increased overdose deaths among people experiencing homelessness, as some had feared at the start of the program.15 The all-cause and overdose-specific mortality rates were lower for shelter-in-place guests than for other people experiencing homelessness, despite their targeting individuals at higher risk of mortality.

Of note, our findings stand in contrast to those elsewhere in the country. For example, in New York City in fiscal year 2020, COVID-19 was the second leading cause of death (after overdose) among people experiencing homelessness (121 deaths through June 30, 2020).16 While there is no standard tracking of deaths among people experiencing homelessness across the US, 1 grassroots effort has compiled publicly available documentation to discover that there have been at least 553 deaths due to COVID-19 among people experiencing homelessness across 23 US cities and counties.17

Limitations

The limitations of this study include our lack of data on non-OCME cases and reliance on point-in-time data to estimate people experiencing homelessness.18 Through their mandate to process all sudden, unexpected, violent, unobserved, overdose, and indigent deaths in San Francisco, the OCME handles most, but not all, deaths among people experiencing homelessness.

There are some system touchpoints not captured by the CCMS, including substance use harm reduction services. Considering the very high prevalence of substance-involved deaths in our study population, having these data would provide important details on additional service encounters prior to death. The CCMS also does not include medical records from certain non-SFDPH health care facilities (eg, Veterans Health Administration records) and does not capture homelessness history from other regions.

Conclusions

Our findings highlight the importance of tracking deaths among people experiencing homelessness. Examining the cause of death and the location of decedents is critical; without these data, one might have assumed that the increased deaths in the pandemic year were due to COVID-19 infection. Finally, having mortality data linked with other service use data (eg, health care services) allows for the identification of potential gaps and points of intervention to prevent deaths.

Back to top
Article Information

Accepted for Publication: January 23, 2022.

Published: March 10, 2022. doi:10.1001/jamanetworkopen.2022.1870

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Cawley C et al. JAMA Network Open.

Corresponding Author: Caroline Cawley, MPH, Department of Emergency Medicine, University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA 94110 (caroline.cawley@ucsf.edu).

Author Contributions: Ms Cawley had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Cawley, Kanzaria, Zevin, Kushel, Raven.

Acquisition, analysis, or interpretation of data: Cawley, Kanzaria, Zevin, Doran, Kushel.

Drafting of the manuscript: Cawley, Kanzaria.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Cawley.

Obtained funding: Kanzaria, Kushel.

Administrative, technical, or material support: Cawley, Kanzaria, Kushel.

Supervision: Kanzaria, Zevin, Doran, Kushel, Raven.

Conflict of Interest Disclosures: Drs Kushel, Raven, and Kanzaria receive salary support from the Benioff Homelessness and Housing Initiative, which was supported by a philanthropic gift from Marc and Lynne Benioff. Dr Kushel reported receiving grants from the National Institutes of Health outside the submitted work. No other disclosures were reported.

Additional Contributions: The authors thank the San Francisco Office of the Chief Medical Examiner and the Whole Person Integrated Care team at the San Francisco Department of Public Health for their partnership.

References
1.
Cawley  CL, Kanzaria  HK, Kushel  M, Raven  MC, Zevin  B.  Mortality among people experiencing homelessness in San Francisco 2016-2018.   J Gen Intern Med. 2021. doi:10.1007/s11606-021-06769-7 PubMedGoogle Scholar
2.
Imbert  E, Kinley  PM, Scarborough  A,  et al.  Coronavirus disease 2019 outbreak in a San Francisco homeless shelter.   Clin Infect Dis. 2021;73(2):324-327. doi:10.1093/cid/ciaa1071 PubMedGoogle ScholarCrossref
3.
City and County of San Francisco. COVID-19 Alternative Shelter Program. SF.gov. COVID-19 data and reports. Accessed August 27, 2021. https://sf.gov/data/covid-19-alternative-shelter-program
4.
Office of the Chief Medical Examiner. How is a medical examiner different from a coroner? City and County of San Francisco. Accessed February 1, 2022. https://sf.gov/information/how-medical-examiner-different-coroner
5.
Kanzaria  HK, Niedzwiecki  M, Cawley  CL,  et al.  Frequent emergency department users: focusing solely on medical utilization misses the whole person.   Health Aff (Millwood). 2019;38(11):1866-1875. doi:10.1377/hlthaff.2019.00082 PubMedGoogle ScholarCrossref
6.
Henry  M, De Sousa  T, Roddey  C, Gayen  S, Bednar  TJ. The 2020 Annual Homeless Assessment Report (AHAR) to Congress. US Department of Housing and Urban Development, Office of Community Planning and Development. Accessed February 1, 2022. https://www.huduser.gov/portal/sites/default/files/pdf/2020-AHAR-Part-1.pdf
7.
San Francisco Department of Homelessness and Supportive Housing.  San Francisco Homeless Count and Survey, Comprehensive Report. Applied Survey Research; 2020.
8.
United States Census Bureau. QuickFacts. San Francisco County California. Accessed February 1, 2022. https://www.census.gov/quickfacts/sanfranciscocountycalifornia
9.
Riley  ED, Raven  MC, Dilworth  SE, Braun  C, Imbert  E, Doran  KM.  Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic.   Int J Drug Policy. 2021;97:103405. doi:10.1016/j.drugpo.2021.103405 PubMedGoogle Scholar
10.
Woolf  SH, Chapman  DA, Sabo  RT, Zimmerman  EB.  Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021.   JAMA. 2021;325(17):1786-1789. doi:10.1001/jama.2021.5199 PubMedGoogle ScholarCrossref
11.
Mattson  CL, Tanz  LJ, Quinn  K, Kariisa  M, Patel  P, Davis  NL.  Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013-2019.   MMWR Morb Mortal Wkly Rep. 2021;70(6):202-207. doi:10.15585/mmwr.mm7006a4 PubMedGoogle ScholarCrossref
12.
Fine  DR, Dickins  KA, Adams  LD,  et al.  Drug overdose mortality among people experiencing homelessness, 2003 to 2018.   JAMA Netw Open. 2022;5(1):e2142676. doi:10.1001/jamanetworkopen.2021.42676 PubMedGoogle Scholar
13.
Doran  KM, Fockele  CE, Maguire  M.  Overdose and homelessness—why we need to talk about housing.   JAMA Netw Open. 2022;5(1):e2142685. doi:10.1001/jamanetworkopen.2021.42685 PubMedGoogle Scholar
14.
Appa  A, Rodda  LN, Cawley  C,  et al.  Drug overdose deaths before and after shelter-in-place orders During the COVID-19 pandemic in San Francisco.   JAMA Netw Open. 2021;4(5):e2110452. doi:10.1001/jamanetworkopen.2021.10452 PubMedGoogle Scholar
16.
New York City Department of Health and Mental Hygiene, New York City Department of Homeless Services. Fifteenth Annual Report on Deaths among Persons Experiencing Homelessness (July 1, 2019 – June 30, 2020). Accessed February 1, 2022. https://a860-gpp.nyc.gov/concern/nyc_government_publications/pz50gz035?locale=en
17.
Fowle  M, Gray  F. COVID-19 homeless deaths. Homeless Deaths Count. Accessed January 15, 2022. https://homelessdeathscount.org/data/covid-19/
18.
Cowan  J. San Francisco’s homeless population is much bigger than thought, city data suggests. New York Times. November 19, 2019. Accessed January 15, 2022. https://www.nytimes.com/2019/11/19/us/san-francisco-homeless-count.html